Stock Prediction and Forecast [CLX]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 04 Nov 2025, 04:47 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Stock Prediction and Forecast [CLX]](https://i.ytimg.com/vi/33F5A-0qq64/hqdefault.jpg)
AI-generated source summary
Clorox Company (CLX) has been identified as a Strong Sell Candidate, registering a score of -5.519. The stock experienced a -2.95% loss over the past two days, averaging -1.48% daily. Technical analysis indicates a broken downward short-term trend, with further decline anticipated. Key resistance levels are noted at $113.04 and $119.44. A 3-month analysis suggests a potential decrease of 6.04%, leading to a projected target price of $102.55. The 12-month outlook forecasts a -32.59% change, with a future price range between $65.68 and $79.31. The last closing price was $109.14. Weekly volatility stands at 2.55%, with no substantial support levels found below the current price, indicating potential sharp declines. Fundamental insights reveal a challenging Q1 fiscal year 2026, with a 19% sales decline and reduced earnings attributed to an ERP system transition and broader macroeconomic headwinds. Analyst ratings are predominantly 'Underweight' or 'Neutral'. The P/E ratio is 16.60, with the Q3 2025 earnings report expected on November 3rd, 2025, and a consensus estimate of $0.82. Insider trading data shows a positive insider power of 48.265, with insiders buying 400,658 shares and selling 133,090 shares in the last 100 transactions, which presents a contradictory signal. No specific stop-loss is suggested in the analysis. For Tuesday, November 4th, the stock is expected to open higher by $0.91, trading at $110.05.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.